Healthcare - Biotechnology - NASDAQ - US
$ 0.4535
-1.26 %
$ 11.4 M
Market Cap
-0.44
P/E
BALANCE SHEET
74.4 M
ASSETS
9.48 M
LIABILITIES
64.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Sensei Biotherapeutics, Inc.
| Current Assets | 67.2 M |
| Cash & Short-Term Investments | 65.8 M |
| Receivables | 0 |
| Other Current Assets | 1.49 M |
| Non-Current Assets | 7.12 M |
| Long-Term Investments | 0 |
| PP&E | 7.04 M |
| Other Non-Current Assets | 86 K |
| Current Liabilities | 5.64 M |
| Accounts Payable | 1.69 M |
| Short-Term Debt | 4.88 M |
| Other Current Liabilities | -929 K |
| Non-Current Liabilities | 3.84 M |
| Long-Term Debt | 3.77 M |
| Other Non-Current Liabilities | 67 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 13.0 | 17.8 | 7.2 | 16.6 | 0.3 | 0.7 |
| Short Term Investments | 52.7 | 89.3 | 140.5 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.5 | 1.5 | 0.9 | 3.5 | 0.3 | 0.6 |
| Total Current Assets | 67.2 | 108.6 | 148.5 | 20.1 | 0.5 | 1.3 |
| PP&E | 7.0 | 9.7 | 4.6 | 1.3 | 0.3 | 0.1 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 86 K | 63 K | 39 K | 86 K | 0.4 | 0.4 |
| Other Assets | 0 | 1 K | 0 | 0 | 0 | 0 |
| Total Assets | 74.4 | 118.4 | 153.2 | 21.4 | 1.2 | 1.9 |
| LIABILITIES | ||||||
| Accounts Payable | 1.7 | 4.5 | 2.5 | 3.9 | 3.5 | 1.1 |
| Short Term Debt | 4.9 | 4.3 | 1.4 | 32 K | 16.1 | 0.7 |
| Other Current Liabilities | (0.9) | 0.3 | 1.1 | 0.9 | 2.2 | 0.9 |
| Total Current Liabilities | 5.6 | 9.1 | 4.9 | 4.8 | 21.7 | 2.7 |
| Long Term Debt | 3.8 | 5.9 | 1.7 | 0.7 | 0 | 4.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 67 K | 0 | 0.1 | 52 K | 48.2 | 48.6 |
| Total Liabilities | 9.5 | 15.0 | 6.7 | 77.9 | 69.9 | 55.3 |
| EQUITY | ||||||
| Common Stock | 3 K | 3 K | 3 K | 0 | 2 K | 2 K |
| Retained Earnings | (231.9) | (197.8) | (149.2) | (112.4) | (92.3) | (75.6) |
| Other Accumulative Comprehensive Income/Loss | (0.2) | (1.0) | (0.3) | 0 | 2 K | (0.3) |
| Total Equity | 64.9 | 103.4 | 146.5 | (56.4) | (68.7) | (53.5) |
| Total Liabilities and Equity | 74.4 | 118.4 | 153.2 | 21.4 | 1.2 | 1.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 28.0 | 30.7 | 27.7 | 30.6 | 29.3 | 0.7 |